Abstract
Every cell requires energy which they obtain from oxidative phosphorylation to perform major metabolic functions. This energy requirement is dependent on their metabolic rate, and it is expected that higher the metabolic rate, higher is the amount of energy expended. However, cancer cells have a unique metabolic behavior where they require only a minimal amount of energy, exhibiting a condition called the Warburg effect to survive and proliferate. They undergo glycolysis despite the availability of adequate oxygen (aerobic glycolysis) and obtain less energy as compared to normal cells from this process. This finding has helped many researchers to look for an alternative in treating cancer which is one of the leading causes of death today. This chapter will elucidate on the role of Warburg effect in modulating cancer cell metabolism and describe recent findings on this unique pathway employed by cancer cells. The chapter will also shed light on an alternative model called the reverse Warburg effect that provides an environment rich in energy for tumor growth and discuss the potential of using this pathway for therapeutically targeting cancer cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Haleem AM, Lewis NE, Jamshidi N, Mineta K, Gao X, Gojobori T (2017) The emerging facets of non-cancerous Warburg effect. Front Endocrinol 8:1–7. https://doi.org/10.3389/fendo.2017.00279
Adekola K, Rosen ST, Shanmugam M (2012) Glucose transporters in cancer metabolism. Curr Opin Oncol 24:650–654. https://doi.org/10.1097/CCO.0b013e328356da72
Barron CC, Bilan PJ, Tsakiridis T, Tsiani E (2016) Facilitative glucose transporters: implications for cancer detection, prognosis and treatment. Metabolism 65:124–139. https://doi.org/10.1016/j.metabol.2015.10.007
Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Witkiewicz AK, Vander Heiden MG, Migneco G, Chiavarina B, Frank PG, Capozza F, Flomenberg N, Martinez-Outschoorn UE, Sotgia F, Lisanti MP (2010) The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle 9:1960–1971. https://doi.org/10.4161/cc.9.10.11601
Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC (2015) Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep 42:841–851. https://doi.org/10.1007/s11033-015-3858-x
Dang CV (2010) Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 70:859–863. https://doi.org/10.1158/0008-5472.CAN-09-3556
Danhier P, Ba P, Payen VL, Grasso D, Ippolito L, Sonveaux P, Porporato PE (2017) Cancer metabolism in space and time: beyond the Warburg effect. Biochim Biophys Acta 1858:556–572. https://doi.org/10.1016/j.bbabio.2017.02.001
Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB (2004) Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 64:3892–3899. https://doi.org/10.1158/0008-5472.CAN-03-2904
Fadaka A, Ajiboye B, Ojo O, Adewale O, Olayide I, Emuowhochere R (2017) Biology of glucose metabolization in cancer cells. J Oncol Sci 3:45–51. https://doi.org/10.1016/j.jons.2017.06.002
Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z, Dupuy F, Chambers C, Fuerth BJ, Viollet B, Mamer OA, Avizonis D, Deberardinis RJ, Siegel PM, Jones RG (2013) AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab 17:113–124. https://doi.org/10.1016/j.cmet.2012.12.001
Feng Y, Liu J, Guo W, Guan Y, Xu H, Guo Q, Song X, Yi F, Liu T, Zhang W, Dong X, Cao LL, O’Rourke BP, Cao LL (2018) Atg7 inhibits Warburg effect by suppressing PKM2 phosphorylation resulting reduced epithelial-mesenchymal transition. Int J Biol Sci 14:755–783. https://doi.org/10.7150/ijbs.26077
Finley LWS, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, Pandolfi PP, Haigis MC (2011) SIRT3 opposes reprogramming of cancer cell metabolism through HIF1$α$ destabilization. Cancer Cell 19:416–428. https://doi.org/10.1016/j.ccr.2011.02.014
Fu Y, Liu S, Yin S, Niu W, Xiong W, Tan M, Li G, Zhou M (2017) The reverse Warburg effect is likely to be an Achilles’ heel of cancer that can be exploited for cancer therapy. Oncotarget 8:57813–57825. https://doi.org/10.18632/oncotarget.18175
Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891–899. https://doi.org/10.1038/nrc1478
Gonzalez CD, Alvarez S, Ropolo A, Rosenzvit C, Gonzalez Bagnes MF, Vaccaro MI (2014) Autophagy, Warburg, and Warburg reverse effects in human cancer. Biomed Res Int 2014:1–10. https://doi.org/10.1155/2014/926729
Gottlieb E, Tomlinson IPM (2005) Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5:857–866. https://doi.org/10.1038/nrc1737
Hitosugi T, Kang S, Heiden MGV, Chung T-w, Elf S, Lythgoe K, Dong S, Lonial S, Wang X, Chen GZ, Xie J, Gu T-l, Polakiewicz RD, Roesel JL, Boggon TJ, Khuri FR, Gilliland DG, Cantley LC, Kaufman J, Chen J (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2:ra73
Horak CE, Lee JH, Marshall JC, Shreeve SM, Steeg PS (2008) The role of metastasis suppressor genes in metastatic dormancy. APMIS 116:586. https://doi.org/10.1111/j.1600-0463.2008.01027.x
Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134:703. https://doi.org/10.1016/j.cell.2008.08.021
Hsu CC, Tseng LM, Lee HC (2016) Role of mitochondrial dysfunction in cancer progression. Exp Biol Med 241:1281–1295. https://doi.org/10.1177/1535370216641787
Jiang B (2017) Aerobic glycolysis and high level of lactate in cancer metabolism and microenvironment. Genes Dis 4:25–27. https://doi.org/10.1016/j.gendis.2017.02.003
Kato Y, Maeda T, Suzuki A (2018) Cancer metabolism : new insights into classic characteristics. Jpn Dent Sci Rev 54:8–21. https://doi.org/10.1016/j.jdsr.2017.08.003
Kim J-W, Dang CV (2005) Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 30:142–150. https://doi.org/10.1016/j.tibs.2005.01.005
Kim J-w, Dang CV (2006) Cancer’s molecular sweet tooth and the Warburg effect. Cancer Res 66:8927–8931. https://doi.org/10.1158/0008-5472.CAN-06-1501
Kim JW, Tchernyshyov I, Semenza GL, Dang CV (2006) HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 3:177–185. https://doi.org/10.1016/j.cmet.2006.02.002
Kondoh H (2012) Glycolytic enzymes can modulate cellular life span. Cancer Res 65:177–186
Legg PD, Chaplin JF, Williamson RE (2010) Genetic diversity in burley and flue-cured Tobacco1. Crop Sci 17:943. https://doi.org/10.2135/cropsci1977.0011183x001700060032x
Li F, Wang Y, Zeller KI, Potter JJ, Wonsey DR, O’Donnell KA, Kim J-w, Yustein JT, Lee LA, Dang CV (2005) Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 25:6225–6234. https://doi.org/10.1128/mcb.25.14.6225-6234.2005
Liberti MV, Locasale JW (2016) The Warburg effect : how does it benefit cancer cells ? Trends Biochem Sci 41:211–218. https://doi.org/10.1016/j.tibs.2015.12.001
Liu W, Beck BH, Vaidya KS, Nash KT, Feeley KP, Ballinger SW, Pounds KM, Denning WL, Diers AR, Landar A, Dhar A, Iwakuma T, Welch DR (2014) Metastasis suppressor KISS1Seemsto reverse the Warburg effect by enhancing mitochondrial biogenesis. Cancer Res 74:954. https://doi.org/10.1158/0008-5472.CAN-13-1183
Lu H, Forbes RA, Verma A (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277:23111–23115. https://doi.org/10.1074/jbc.M202487200
Manley SJ, Liu W, Welch DR (2017) The KISS1 metastasis suppressor appears to reverse the Warburg effect by shifting from glycolysis to mitochondrial beta-oxidation. J Mol Med 95:951. https://doi.org/10.1007/s00109-017-1552-2
Mathupala SP, Ko YH, Pedersen PL (2009) Hexokinase-2 bound to mitochondria: cancer’s stygian link to the “Warburg effect” and a pivotal target for effective therapy. Semin Cancer Biol 19:17–24. https://doi.org/10.1016/j.semcancer.2008.11.006
Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM (2006) P53 regulates mitochondrial respiration. Science 312:1650–1653. https://doi.org/10.1126/science.1126863
Miles KA, Williams RE (2008) Warburg revisited : imaging tumour blood flow and. Metabolism 8:81–86. https://doi.org/10.1102/1470-7330.2008.0011
Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC (2006) HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3:187–197. https://doi.org/10.1016/j.cmet.2006.01.012
Pavlides S, Whitaker-Menezes D, Castello-Cros R, Flomenberg N, Witkiewicz AK, Frank PG, Casimiro MC, Wang C, Fortina P, Addya S, Pestell RG, Martinez-Outschoorn UE, Sotgia F, Lisanti MP (2009) The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 8:3984–4001. https://doi.org/10.4161/cc.8.23.10238
Plas DR, Thompson CB (2005) Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24:7435–7442. https://doi.org/10.1038/sj.onc.1209097
Potter M, Newport E, Morten KJ (2016) The Warburg effect: 80 years on. Biochem Soc Trans 44:1499–1505. https://doi.org/10.1042/bst20160094
Samudio I, Fiegl M, Andreeff M (2009) Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism. Cancer Res 69:2163–2166. https://doi.org/10.1158/0008-5472.CAN-08-3722
Sawayama H, Ishimoto T, Sugihara H, Miyanari N, Miyamoto Y, Baba Y, Yoshida N, Baba H (2014) Clinical impact of the Warburg effect in gastrointestinal cancer (Review). Int J Oncol 45:1345–1354. https://doi.org/10.3892/ijo.2014.2563
Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721–732. https://doi.org/10.1038/nrc1187
Semenza GL (2010) HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev 20:51–56. https://doi.org/10.1016/j.gde.2009.10.009
Shan M, Dai D, Vudem A, Varner JD, Stroock AD (2018) Multi-scale computational study of the Warburg effect, reverse Warburg effect and glutamine addiction in solid tumors. PLoS Comput Biol 14:1–30. https://doi.org/10.1371/journal.pcbi.1006584
Shanmugam M, McBrayer SK, Rosen ST (2009) Targeting the Warburg effect in hematological malignancies: from PET to therapy. Curr Opin Oncol 21:531–536. https://doi.org/10.1097/CCO.0b013e32832f57ec
Siddiqui FA, Prakasam G, Chattopadhyay S, Rehman AU, Padder RA, Ansari MA, Irshad R, Mangalhara K, Bamezai RNK, Husain M, Ali SM, Iqbal MA (2018) Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1$α$ inhibition. Sci Rep 8:2–10. https://doi.org/10.1038/s41598-018-25524-3
Tran Q, Lee H, Park J, Kim S-h, Park J (2016) Targeting cancer metabolism – revisiting the Warburg effects. Toxicol Res 32:177–193. https://doi.org/10.5487/TR.2016.32.3.177
Vander Heiden MG (2012) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029. https://doi.org/10.1126/science.1160809
Vazquez A, Liu J, Zhou Y, Oltvai ZN (2010) Catabolic efficiency of aerobic glycolysis: the Warburg effect revisited. BMC Syst Biol 4:58
Vyas S, Zaganjor E, Haigis MC (2016) Mitochondria and cancer. Cell 166:555–566. https://doi.org/10.1016/j.cell.2016.07.002
Wang L, Wang J, Xiong H, Wu F, Lan T, Zhang Y, Guo X, Wang H, Saleem M, Jiang C, Lu J, Deng Y (2016) Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer. EBioMedicine 7:50–61. https://doi.org/10.1016/j.ebiom.2016.03.022
Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8(6):519–530
Wilde L, Roche M, Domingo-Vidal M, Tanson K, Philp N, Curry J, Martinez-Outschoorn U (2017) Metabolic coupling and the reverse Warburg effect in cancer: implications for novel biomarker and anticancer agent development. Semin Oncol 44:198–203. https://doi.org/10.1053/j.seminoncol.2017.10.004
Wu WKK, Coffelt SB, Cho CH, Wang XJ, Lee CW, Chan FKL, Yu J, Sung JJY (2012) The autophagic paradox in cancer therapy. Oncogene 31:939–953. https://doi.org/10.1038/onc.2011.295
Wu C-A, Chao Y, Shiah S-G, Lin W-W (2013) Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase. Biochim Biophys Acta 1833:1147–1156. https://doi.org/10.1016/j.bbamcr.2013.01.025
Yang W, Lu Z (2013) Nuclear PKM2 regulates the Warburg effect. Cell Cycle 12:3154–3158. https://doi.org/10.4161/cc.26182
Yoshida GJ (2015) Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res 34:1–10. https://doi.org/10.1186/s13046-015-0221-y
Yu L, Chen X, Sun X, Wang L, Chen S (2017) The glycolytic switch in tumors: how many players are involved? J Cancer 8:3430–3440. https://doi.org/10.7150/jca.21125
Zawacka-Pankau J, Grinkevich VV, Hünten S, Nikulenkov F, Gluch A, Li H, Enge M, Kel A, Selivanova G (2011) Inhibition of glycolytic enzymes mediated by pharmacologically activated p53. J Biol Chem 286:41600–41615. https://doi.org/10.1074/jbc.m111.240812
Zhang C, Liu J, Liang Y, Wu R, Zhao Y, Hong X, Lin M, Yu H, Liu L, Levine AJ, Hu W, Feng Z (2013) Tumour-associated mutant p53 drives the Warburg effect. Nat Commun 4:2935. https://doi.org/10.1038/ncomms3935
Acknowledgments
The authors would like to thank Keerthika J. Jayachandran for helping them with the graphic design of Fig. 2.1.
Financial support: S.H. laboratory is supported by selective excellence initiative grant from the SRM Institute of Science and Technology.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Narayanan, S., Santhoshkumar, A., Ray, S., Harihar, S. (2020). Reprogramming of Cancer Cell Metabolism: Warburg and Reverse Warburg Hypothesis. In: Kumar, D. (eds) Cancer Cell Metabolism: A Potential Target for Cancer Therapy. Springer, Singapore. https://doi.org/10.1007/978-981-15-1991-8_2
Download citation
DOI: https://doi.org/10.1007/978-981-15-1991-8_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-1990-1
Online ISBN: 978-981-15-1991-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)